Hereditary parkinsonism with dementia is caused by mutations in ATP13A2, encoding a lysosomal type 5 P-type ATPase
The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
Neurodegenerative disorders such as Parkinson and Alzheimer disease cause motor and cognitive dysfunction and belong to a heterogeneous group of common and disabling disorders. Although the complex molecular pathophysiology of neurodegeneration is largely unknown, major advances have been achieved by elucidating the genetic defects underlying mendelian forms of these diseases. This has led to the discovery of common pathophysiological pathways such as enhanced oxidative stress, protein misfolding and aggregation and dysfunction of the ubiquitin-proteasome system. Here, we describe loss-of-function mutations in a previously uncharacterized, predominantly neuronal P-type ATPase gene, ATP13A2, underlying an autosomal recessive form of early-onset parkinsonism with pyramidal degeneration and dementia (PARK9, Kufor-Rakeb syndrome). Whereas the wild-type protein was located in the lysosome of transiently transfected cells, the unstable truncated mutants were retained in the endoplasmic reticulum and degraded by the proteasome. Our findings link a class of proteins with unknown function and substrate specificity to the protein networks implicated in neurodegeneration and parkinsonism.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A similar phenotype has also been described in the context of loss‐of‐function mutations in the P‐type ATPase gene ATP13A2, in which recessive, early‐onset PD has been linked to defective acidification of lysosomes and insufficient autophagy (Ramirez et al, 2006).”
From Autophagy in major human diseases (2021) · cites this paper as Ramirez et al, 2006
Citations
Cites
Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism
Kitada, T., Asakawa, S., Hattori, N., Matsumine, H., Yamamura, Y., Minoshima, S., Yokochi, M., Mizuno, Y., & Shimizu, N. (1998) · Nature · doi:10.1038/33416 · Cited by 5,227 · cited 1×
“By mutation screening or linkage analysis, we excluded the known autosomal recessive Parkinson disease genes and loci: PARK2 (also known as Parkin ; ref”
BackgroundHereditary Early-Onset Parkinson's Disease Caused by Mutations in PINK1
Valente, E. M., Abou-Sleiman, P. M., Caputo, V., Muqit, M. M. K., Harvey, K., Gispert, S., Ali, Z., Del Turco, D., Bentivoglio, A. R., Healy, D. G., et al. (2004) · Science · doi:10.1126/science.1096284 · Cited by 3,481
The RIN: an RNA integrity number for assigning integrity values to RNA measurements
Schroeder, A., Mueller, O., Stocker, S., Salowsky, R., Leiber, M., Gassmann, M., Lightfoot, S., Menzel, W., Granzow, M., & Ragg, T. (2006) · BMC Molecular Biology · doi:10.1186/1471-2199-7-3 · Cited by 2,623
Impaired Degradation of Mutant α-Synuclein by Chaperone-Mediated Autophagy
Cuervo, A. M., Stefanis, L., Fredenburg, R., Lansbury, P. T., & Sulzer, D. (2004) · Science · doi:10.1126/science.1101738 · Cited by 2,024
Molecular Pathways of Neurodegeneration in Parkinson's Disease
Dawson, T. M., & Dawson, V. L. (2003) · Science · doi:10.1126/science.1087753 · Cited by 1,663
α-Synuclein Is Degraded by Both Autophagy and the Proteasome
Webb, J. L., Ravikumar, B., Atkins, J., Skepper, J. N., & Rubinsztein, D. C. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300227200 · Cited by 1,429
Alzheimer's Disease and Parkinson's Disease
Nussbaum, R. L., & Ellis, C. E. (2003) · New England Journal of Medicine · doi:10.1056/nejm2003ra020003 · Cited by 1,351
Proteolysis: from the lysosome to ubiquitin and the proteasome
Ciechanover, A. (2005) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1552 · Cited by 1,133
Evolution of Substrate Specificities in the P-Type ATPase Superfamily
Axelsen, K. B., & Palmgren, M. G. (1998) · Journal of Molecular Evolution · doi:10.1007/pl00006286 · Cited by 910
Cell biology of protein misfolding: the examples of Alzheimer's and Parkinson's diseases
Selkoe, D. J. (2004) · Nature Cell Biology · doi:10.1038/ncb1104-1054 · Cited by 863
Cited by
Items 401–500 of 1,000
Ye, B., Wang, Q., Hu, H., Shen, Y., Cui, F., Chen, P., Ma, Y., Wu, H., & Xiang, M. (2019) · Autophagy · doi:10.1080/15548627.2019.1569926 · Cited by 67
Mitochondrial kinases in Parkinson’s disease: Converging insights from neurotoxin and genetic models
Dagda, R. K., Zhu, J., & Chu, C. T. (2009) · Mitochondrion · doi:10.1016/j.mito.2009.06.001 · Cited by 70
Genetic models of Parkinson disease
Lim, K., & Ng, C.-H. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2008.10.005 · Cited by 72
Harbo, H. F., Finsterer, J., Baets, J., Broeckhoven, C. V., Donato, S. D., Fontaine, B., Jonghe, P. D., Lossos, A., Lynch, T., Mariotti, C., et al. (2009) · European Journal of Neurology · doi:10.1111/j.1468-1331.2009.02646.x · Cited by 69
Dodson, M. W., Leung, L. K., Lone, M., Lizzio, M. A., & Guo, M. (2014) · Disease Models & Mechanisms · doi:10.1242/dmm.017020 · Cited by 59
Neurodegeneration with Brain Iron Accumulation
Schneider, S. A. (2016) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-015-0608-3 · Cited by 68
Loss of HSPA9 induces peroxisomal degradation by increasing pexophagy
Jo, D. S., Park, S. J., Kim, A., Park, N. Y., Kim, J. B., Bae, J.-E., Park, H. J., Shin, J. H., Chang, J. W., Kim, P. K., et al. (2020) · Autophagy · doi:10.1080/15548627.2020.1712812 · Cited by 69
Lack of replication of association between GIGYF2 variants and Parkinson disease
Brás, J., Simón‐Sánchez, J., Federoff, M., Morgadinho, A., Januário, C., Ribeiro, M., Cunha, L., Oliveira, C. R., & Singleton, A. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddn340 · Cited by 64
Novel mutation in ATP13A2 widens the spectrum of Kufor‐Rakeb syndrome (PARK9)
Eiberg, H., Hansen, L. H., Korbo, L., Nielsen, I., Svenstrup, K., Bech, S., Pinborg, L. H., Friberg, L., Hjermind, L., Olsen, O., et al. (2011) · Clinical Genetics · doi:10.1111/j.1399-0004.2011.01745.x · Cited by 63
Cross-talk between mitochondria and proteasome in Parkinson’s disease pathogenesis
Martins-Branco, D. A., Arduíno, D. M., Esteves, A. R., Silva, D. F. F., Cardoso, S. M., & Oliveira, C. R. (2010) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2010.00017 · Cited by 74
Profiling of Parkin-Binding Partners Using Tandem Affinity Purification
Zanon, A., Rakovic, A., Blankenburg, H., Doncheva, N. T., Schwienbacher, C., Serafin, A., Alexa, A., Weichenberger, C. X., Albrecht, M., Klein, C., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0078648 · Cited by 61
Moving towards a new era of genomics in the neuronal ceroid lipofuscinoses
Butz, E. S., Chandrachud, U., Mole, S. E., & Cotman, S. L. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2019.165571 · Cited by 62
Lysoplex: An efficient toolkit to detect DNA sequence variations in the autophagy-lysosomal pathway
Di Fruscio, G., Schulz, A., De Cegli, R., Savarese, M., Mutarelli, M., Parenti, G., Banfi, S., Braulke, T., Nigro, V., & Ballabio, A. (2015) · Autophagy · doi:10.1080/15548627.2015.1043077 · Cited by 62
Higashi, S., Moore, D. J., Minegishi, M., Kasanuki, K., Fujishiro, H., Kabuta, T., Togo, T., Katsuse, O., Uchikado, H., Furukawa, Y., et al. (2011) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e318211c86a · Cited by 61
Identification of a novel Parkinson’s disease locus via stratified genome-wide association study
Hill‐Burns, E. M., Wissemann, W. T., Hamza, T. H., Factor, S. A., Zabetian, C. P., & Payami, H. (2014) · BMC Genomics · doi:10.1186/1471-2164-15-118 · Cited by 68
Wei, J., Fujita, M., Nakai, M., Waragai, M., Sekigawa, A., Sugama, S., Takenouchi, T., Masliah, E., & Hashimoto, M. (2009) · American Journal Of Pathology · doi:10.2353/ajpath.2009.080680 · Cited by 65
Lysosomal trafficking defects link Parkinson's disease with Gaucher's disease
Wong, Y. C., & Krainc, D. (2016) · Movement Disorders · doi:10.1002/mds.26802 · Cited by 59
Demirsoy, Ş., Martin, S., Motamedi, S., van Veen, S., Holemans, T., den Haute, C. V., Jordanova, A., Baekelandt, V., Vangheluwe, P., & Agostinis, P. (2017) · Human Molecular Genetics · doi:10.1093/hmg/ddx070 · Cited by 61
Role of Astrocytes in Parkinson’s Disease Associated with Genetic Mutations and Neurotoxicants
Kim, S., Pajarillo, E. A. B., Nyarko‐Danquah, I., Aschner, M., & Lee, E.-S. (2023) · Cells · doi:10.3390/cells12040622 · Cited by 62
Lysosomal function in macromolecular homeostasis and bioenergetics in Parkinson's disease
Schneider, L., & Zhang, J. (2010) · Molecular Neurodegeneration · doi:10.1186/1750-1326-5-14 · Cited by 58
Syndromes of Neurodegeneration With Brain Iron Accumulation
Schneider, S. A., & Bhatia, K. P. (2012) · Seminars in Pediatric Neurology · doi:10.1016/j.spen.2012.03.005 · Cited by 60
Lysosomal dysfunction in α-synuclein pathology: molecular mechanisms and therapeutic strategies
Dai, L., Liu, M., Ke, W., Chen, L., Fang, X., & Zhang, Z. (2024) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-024-05419-5 · Cited by 61
Peneder, T. M., Scholze, P., Berger, M. L., Reither, H., Heinze, G., Bertl, J., Bauer, J., Richfield, E. K., Hornykiewicz, O., & Pifl, C. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.02.017 · Cited by 64
The lysosomal storage disease continuum with ageing-related neurodegenerative disease
Lloyd‐Evans, E., & Haslett, L. J. (2016) · Ageing Research Reviews · doi:10.1016/j.arr.2016.07.005 · Cited by 62
Rare Variants in Specific Lysosomal Genes Are Associated With Parkinson's Disease
Hopfner, F., Mueller, S. H., Szymczak, S., Junge, O., Tittmann, L., May, S., Lohmann, K., Grallert, H., Lieb, W., Strauch, K., et al. (2020) · Movement Disorders · doi:10.1002/mds.28037 · Cited by 60
Recent progress in the role of autophagy in neurological diseases
Meng, T., Lin, S., Zhuang, H., Huang, H., He, Z., Hu, Y., Gong, Q., & Feng, D. (2019) · Cell Stress · doi:10.15698/cst2019.05.186 · Cited by 58
Dexter, P. M., Caldwell, K. A., & Caldwell, G. A. (2012) · Neurotherapeutics · doi:10.1007/s13311-012-0109-x · Cited by 60
Towards Unveiling the Genetics of Neurodegenerative Diseases
Lill, C., & Bertram, L. (2011) · Seminars in Neurology · doi:10.1055/s-0031-1299791 · Cited by 57
Spataro, R., Kousi, M., Farhan, S. M. K., Willer, J. R., Ross, J. P., Dion, P. A., Rouleau, G. A., Daly, M. J., Neale, B. M., Bella, V. L., et al. (2019) · Human Genomics · doi:10.1186/s40246-019-0203-9 · Cited by 60
Manganese-Induced Parkinsonism: Evidence from Epidemiological and Experimental Studies
Lucchini, R. G., & Tieu, K. (2023) · Biomolecules · doi:10.3390/biom13081190 · Cited by 60
Manzoni, C., & Lewis, P. A. (2017) · Advances in neurobiology · doi:10.1007/978-3-319-49969-7_5 · Cited by 60
Vesicle trafficking and lipid metabolism in synucleinopathy
Fanning, S., Selkoe, D. J., & Dettmer, U. (2020) · Acta Neuropathologica · doi:10.1007/s00401-020-02177-z · Cited by 60
Dysregulated Interorganellar Crosstalk of Mitochondria in the Pathogenesis of Parkinson’s Disease
Sironi, L., Restelli, L. M., Tolnay, M., Neutzner, A., & Frank, S. (2020) · Cells · doi:10.3390/cells9010233 · Cited by 57
Lipids in the Physiopathology of Hereditary Spastic Paraplegias
Darios, F. D., Mochel, F., & Stévanin, G. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00074 · Cited by 57
Zhao, T., de Graaff, E., Breedveld, G. J., Loda, A., Severijnen, L.-A. W. F. M., Wouters, C. H., Verheijen, F. W., Dekker, M. C. J., Montagna, P., Willemsen, R., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016983 · Cited by 56
Structural basis of polyamine transport by human ATP13A2 (PARK9)
Sim, S. I., von Bülow, S., Hummer, G., & Park, E. (2021) · Molecular Cell · doi:10.1016/j.molcel.2021.08.017 · Cited by 57
Advances in Zebrafish as a Comprehensive Model of Mental Disorders
Wang, L., Liu, F., Fang, Y., Ma, J., Wang, J., Qu, L., Yang, Q., Wu, W., Jin, L., & Sun, D. (2023) · Depression and Anxiety · doi:10.1155/2023/6663141 · Cited by 65
Chesi, A., Kilaru, A. S., Fang, X., Cooper, A. A., & Gitler, A. D. (2012) · PLoS ONE · doi:10.1371/journal.pone.0034178 · Cited by 61
Excess iron harms the brain: the syndromes of neurodegeneration with brain iron accumulation (NBIA)
Schneider, S. A., & Bhatia, K. P. (2012) · Journal of Neural Transmission · doi:10.1007/s00702-012-0922-8 · Cited by 60
Enhanced Lysosomal Pathology Caused by β-Synuclein Mutants Linked to Dementia with Lewy Bodies
Wei, J., Fujita, M., Nakai, M., Waragai, M., Watabe, K., Akatsu, H., Rockenstein, E. M., Masliah, E., & Hashimoto, M. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m703711200 · Cited by 55
Disturbance of redox homeostasis in Down Syndrome: Role of iron dysmetabolism
Barone, E., Arena, A., Head, E., Butterfield, D. A., & Perluigi, M. (2018) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2017.07.009 · Cited by 54
Interplay between the ubiquitin-proteasome system and autophagy in proteinopathies.
Zheng, Q., Li, J., & Wang, X. (2009) · Europe PMC (PubMed Central) · Cited by 70
Genetic causes of Parkinson's disease and their links to autophagy regulation
Pan, P., & Yue, Z. (2013) · Parkinsonism & Related Disorders · doi:10.1016/s1353-8020(13)70037-3 · Cited by 58
Genetics and iron in the systems biology of Parkinson’s disease and some related disorders
Funke, C., Schneider, S. A., Berg, D., & Kell, D. B. (2013) · Neurochemistry International · doi:10.1016/j.neuint.2012.11.015 · Cited by 54
Yeast unfolds the road map toward α-synuclein-induced cell death
Franssens, V., Boelen, E., Anandhakumar, J., Vanhelmont, T., Büttner, S., & Winderickx, J. (2009) · Cell Death and Differentiation · doi:10.1038/cdd.2009.203 · Cited by 54
Guerreiro, R., Bras, J., Hardy, J., & Singleton, A. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu203 · Cited by 55
Tickled PINK1: Mitochondrial homeostasis and autophagy in recessive Parkinsonism
Chu, C. T. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2009.06.012 · Cited by 56
Rare Neurodegenerative Diseases: Clinical and Genetic Update
Matilla‐Dueñas, A., Corral‐Juan, M., Rodríguez‐Palmero, A., Vilas, D., Ispierto, L., Morais, S., Sequeiros, J., Alonso, I. D. C. M. P., Volpini, V., Serrano, C., et al. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-67144-4_25 · Cited by 59
Zhu, X., Zhang, H., & Mendell, J. T. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.107895 · Cited by 54
Hypoxia Signaling in Parkinson’s Disease: There Is Use in Asking “What HIF?”
Pinilla, L. L., Ugun‐Klusek, A., Rutella, S., & Girolamo, L. A. D. (2021) · Biology · doi:10.3390/biology10080723 · Cited by 60
Cathepsins D and L reduce the toxicity of advanced glycation end products
Grimm, S., Hörlacher, M., Catalgol, B., Höhn, A., Reinheckel, T., & Grune, T. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.12.021 · Cited by 57
Structural divergence between the two subgroups of P5 ATPases
Sørensen, D. M., Buch-Pedersen, M. J., & Palmgren, M. B. (2010) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2010.04.010 · Cited by 58
DNA methylation in neurodegenerative disorders: a missing link between genome and environment?
Iraola-Guzmán, S., Estivill, X., & Rabionet, R. (2011) · Clinical Genetics · doi:10.1111/j.1399-0004.2011.01673.x · Cited by 52
Fibrillar α-synuclein toxicity depends on functional lysosomes
Guiney, S. J., Adlard, P. A., Lei, P., Mawal, C., Bush, A. I., Finkelstein, D. I., & Ayton, S. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra120.013428 · Cited by 56
Genetics of Parkinson’s disease and parkinsonism
Douglas, M. R., Lewthwaite, A. J., & Nicholl, D. J. (2007) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.7.6.657 · Cited by 52
Role of Autophagy Pathway in Parkinson’s Disease and Related Genetic Neurological Disorders
Themistokleous, C., Bagnoli, E., Parulekar, R., & Muqit, M. M. K. (2023) · Journal of Molecular Biology · doi:10.1016/j.jmb.2023.168144 · Cited by 48
Structural imaging in the presymptomatic stage of genetically determined parkinsonism
Reetz, K., Tadić, V., Kasten, M., Brüggemann, N., Schmidt, A., Hagenah, J. M., Pramstaller, P. P., Ramírez, A., Behrens, M. I., Siebner, H. R., et al. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2010.05.006 · Cited by 54
Self-citationPINK1 enhances insulin-like growth factor-1-dependent Akt signaling and protection against apoptosis
Akundi, R. S., Zhi, L., & Büeler, H. (2012) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.08.034 · Cited by 51
Di Domenico, F., Sultana, R., Ferree, A., Smith, K., Barone, E., Perluigi, M., Coccia, R., Pierce, W., Cai, J., Mancuso, C., et al. (2012) · Antioxidants & Redox Signaling · doi:10.1089/ars.2011.4312 · Cited by 52
The E646D-ATP13A4 Mutation Associated with Autism Reveals a Defect in Calcium Regulation
Vallipuram, J., Grenville, J., & Crawford, D. A. (2009) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-009-9445-8 · Cited by 53
Salomão, R. P. A., Pedroso, J. L., Gama, M. T. D., Dutra, L. A., Maciel, R., Godeiro-Junior, C. D. O., Chien, H. F., Teive, H. A. G., Cardoso, F., & Barsottini, O. G. P. (2016) · Arquivos de Neuro-Psiquiatria · doi:10.1590/0004-282x20160080 · Cited by 53
Bonifati, V. (2007) · Parkinsonism & Related Disorders · doi:10.1016/s1353-8020(08)70008-7 · Cited by 60
Li, H., Zeng, F., Huang, C., Pu, Q., Thomas, E. R., Chen, Y., & Li, X. (2023) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.14411 · Cited by 56
Identification of genetic modifiers of age-at-onset for familial Parkinson’s disease
Hill‐Burns, E. M., Ross, O. A., Wissemann, W. T., Soto‐Ortolaza, A. I., Zareparsi, S., Siuda, J. S., Lynch, T., Wszołek, Z. K., Silburn, P. A., Mellick, G. D., et al. (2016) · Human Molecular Genetics · doi:10.1093/hmg/ddw206 · Cited by 52
Kim, H., Calatayud, C., Guha, S. K., Fernández‐Carasa, I., Berkowitz, L. A., Carballo‐Carbajal, I., Ezquerra, M., Fernández‐Santiago, R., Kapahi, P., Raya, Á., et al. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-0881-7 · Cited by 52
Protein stability and aggregation in Parkinson's disease
Robinson, P. A. (2008) · Biochemical Journal · doi:10.1042/bj20080295 · Cited by 58
Mitochondrial Dysfunction in Genetic and Non-Genetic Parkinson’s Disease
Lucchesi, M., Biso, L., Bonaso, M., Longoni, B., Buchignani, B., Battini, R., Santorelli, F. M., Doccini, S., & Scarselli, M. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26094451 · Cited by 51
Role of magnesium and a phagosomal P-type ATPase in intracellular bacterial killing
Lelong, E., Marchetti, A., Guého, A., de Lima, W. C., Sattler, N., Molmeret, M., Hagedorn, M., Soldati, T., & Cosson, P. (2010) · Cellular Microbiology · doi:10.1111/j.1462-5822.2010.01532.x · Cited by 53
Biochemical and molecular features of LRRK2 and its pathophysiological roles in Parkinson's disease
Seol, W. (2010) · BMB Reports · doi:10.5483/bmbrep.2010.43.4.233 · Cited by 54
Genetic basis of Parkinson disease
Xiromerisiou, G., Dardiotis, E., Tsimourtou, V., Kountra, P., Paterakis, K. N., Kapsalaki, E. Z., Fountas, K. N., & Hadjigeorgiou, G. M. (2009) · Neurosurgical FOCUS · doi:10.3171/2009.10.focus09220 · Cited by 55
Reetz, K., Lencer, R., Steinlechner, S., Gaser, C., Hagenah, J. M., Büchel, C., Petersen, D., Kock, N., Djarmati, A., Siebner, H. R., et al. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.12.010 · Cited by 51
The Parkinson-associated human P5B-ATPase ATP13A2 protects against the iron-induced cytotoxicity
Rinaldi, D. E., Corradi, G. R., Cuesta, L. M., Adamo, H. P., & Pinto, F. D. T. (2015) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2015.04.008 · Cited by 49
Are genetic and idiopathic forms of Parkinson's disease the same disease?
Guedes, L. C., Mestre, T., Outeiro, T. F., & Ferreira, J. J. (2019) · Journal of Neurochemistry · doi:10.1111/jnc.14902 · Cited by 53
Anderson, P. C., & Daggett, V. (2008) · Biochemistry · doi:10.1021/bi800677k · Cited by 49
Courtland, J. L., Bradshaw, T. W., Waitt, G., Soderblom, E. J., Ho, T., Rajab, A., Vancini, R., Kim, I. H., & Soderling, S. H. (2021) · eLife · doi:10.7554/elife.61590 · Cited by 49
Fernandes, T., Domingues, M. R., Moreira, P. I., & Pereira, C. (2023) · Biology · doi:10.3390/biology12030414 · Cited by 51
Genetic Mouse Models of Neurodegenerative Diseases
Trancikova, A. K., Ramonet, D., & Moore, D. J. (2011) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-384878-9.00012-1 · Cited by 54
RNA Binding Proteins and the Pathogenesis of Frontotemporal Lobar Degeneration
Hofmann, J. W., Seeley, W. W., & Huang, E. J. (2019) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathmechdis-012418-012955 · Cited by 47
Renner, H., Schöler, H. R., & Bruder, J. M. (2021) · Movement Disorders · doi:10.1002/mds.28775 · Cited by 49
Mutation in ADORA1 identified as likely cause of early‐onset parkinsonism and cognitive dysfunction
Jaberi, E., Rohani, M., Shahidi, G. A., Nafissi, S., Arefian, E., Soleimani, M., Moghadam, A., Arzenani, M. K., Keramatian, F., Klotzle, B., et al. (2016) · Movement Disorders · doi:10.1002/mds.26627 · Cited by 49
Iron in neurodegenerative disorders: being in the wrong place at the wrong time?
Apostolakis, S., & Kypraiou, A.-M. (2017) · Reviews in the Neurosciences · doi:10.1515/revneuro-2017-0020 · Cited by 49
Advances in the Research of Risk Factors and Prodromal Biomarkers of Parkinson’s Disease
Xie, F., Gao, X., Yang, W., Chang, Z., Yang, X., Wei, X., Huang, Z., Xie, H., Yue, Z., Zhou, F., et al. (2018) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00520 · Cited by 48
Wei, Q., Dong, H., Pan, L.-Y., Chen, C., Yan, Y., Wang, R., Li, H., Liu, Z., Tao, Q., & Wu, Z. (2019) · Translational Neurodegeneration · doi:10.1186/s40035-019-0157-9 · Cited by 47
DNAJC6 Mutations Disrupt Dopamine Homeostasis in Juvenile Parkinsonism‐Dystonia
Ng, J., Cortès‐Saladelafont, E., Abela, L., Termsarasab, P., Mankad, K., Sudhakar, S. V., Gorman, K. M., Heales, S., Pope, S. A. S., Biassoni, L., et al. (2020) · Movement Disorders · doi:10.1002/mds.28063 · Cited by 47
Challenges and Controversies in the Genetic Diagnosis of Hereditary Spastic Paraplegia
Saputra, L., & Kumar, K. R. (2021) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-021-01099-x · Cited by 49
Structure and transport mechanism of P5B-ATPases
Li, P., Wang, K., Salustros, N., Grønberg, C., & Gourdon, P. E. (2021) · Nature Communications · doi:10.1038/s41467-021-24148-y · Cited by 48
Schapira, A. H. V., Hartmann, A., & Agid, Y. (2009) · Wiley eBooks · doi:10.1002/9781444306385.ch3 · Cited by 47
New animal models of Parkinson's disease
Dehay, B., & Bézard, E. (2011) · Movement Disorders · doi:10.1002/mds.23546 · Cited by 48
α-Synuclein in Parkinson's Disease: Pathogenic Function and Translation into Animal Models
Eschbach, J., & Danzer, K. M. (2013) · Neurodegenerative Diseases · doi:10.1159/000354615 · Cited by 47
Covy, J. P., Waxman, E. A., & Giasson, B. I. (2012) · Journal of Neuroscience Research · doi:10.1002/jnr.23112 · Cited by 44
Genetic analysis of the RAB39B gene in Chinese Han patients with Parkinson's disease
Yuan, L., Deng, X., Song, Z. J., Yang, Z., Ni, B., Chen, Y., & Deng, H. (2015) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2015.06.019 · Cited by 47
LRRK2 Promotes Tau Accumulation, Aggregation and Release
Guerreiro, P. S., Gerhardt, E., da Fonseca, T. L., Bähr, M., Outeiro, T. F., & Eckermann, K. (2015) · Molecular Neurobiology · doi:10.1007/s12035-015-9209-z · Cited by 48
Parkinson's disease in Arabs: A systematic review
Benamer, H. T. S., de Silva, R. N., Siddiqui, K. A., & Grosset, D. G. (2008) · Movement Disorders · doi:10.1002/mds.22041 · Cited by 46
Voltage-gated calcium channels and Parkinson's disease
Hurley, M. J., & Dexter, D. T. (2011) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2011.11.006 · Cited by 55
Targeting α‐synuclein: Therapeutic options
Dehay, B., Decressac, M., Bourdenx, M., Guadagnino, I., Fernagut, P., Tamburrino, A., Bassil, F., Meissner, W. G., & Bézard, E. (2016) · Movement Disorders · doi:10.1002/mds.26568 · Cited by 48
Rare Causes of Dystonia Parkinsonism
Schneider, S. A., & Bhatia, K. P. (2010) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-010-0136-0 · Cited by 45
Diagnosis of CoPAN by whole exome sequencing: Waking up a sleeping tiger's eye
Evers, C., Seitz, A., Assmann, B. E., Opladen, T., Karch, S., Hinderhofer, K., Granzow, M., Paramasivam, N., Eils, R., Diessl, N., et al. (2017) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.38252 · Cited by 47
Structural mechanisms for gating and ion selectivity of the human polyamine transporter ATP13A2
Tillinghast, J., Drury, S., Bowser, D., Benn, A., & Lee, K. P. K. (2021) · Molecular Cell · doi:10.1016/j.molcel.2021.10.002 · Cited by 46
Daniel, G., Musso, A., Tsika, E., Fiser, A., Glauser, L., Pletnikova, O., Schneider, B. L., & Moore, D. J. (2015) · Neurobiology of Disease · doi:10.1016/j.nbd.2014.10.007 · Cited by 39
Heinick, A., Urban, K., Roth, S., Spies, D., Nunes, F., Phanstiel, O., Liebau, E., & Lüersen, K. (2009) · The FASEB Journal · doi:10.1096/fj.09-135889 · Cited by 48
Metadata
- Authors
- Ramirez, A., Heimbach, A., Gründemann, J., Stiller, B., Hampshire, D., Cid, L. P., Goebel, I., Mubaidin, A. F., Wriekat, A.-L., Roeper, J., Al-Din, A., Hillmer, A. M., Karsak, M., Liss, B., Woods, C. G., Behrens, M. I., & Kubisch, C.
- Affiliations
- University of Cologne (DE)
- Philipps University of Marburg (DE)
- University of Leeds (GB)
- Centro de Estudios Científicos (CL)
- University of Bonn (DE)
- King Hussein Medical Center (JO)
- Pinderfields Hospital (GB)
- University of Cambridge (GB)
- Corresponding author
- Kubisch, Christian
- ORCID
- Venue
- Nature Genetics
- Published
- 2006-09-10
- Volume
- 38
- Issue
- 10
- Pages
- 1184-1191
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- OpenAlex
- W2139369185
- Cited by
- 1,208
- References
- 30
- Citations by year
- 2026: 42 · 2025: 44 · 2024: 39 · 2023: 49 · 2022: 45 · 2021: 70 · 2020: 73 · 2019: 69 · 2018: 54 · 2017: 64 · 2016: 76 · 2015: 59 · 2014: 57 · 2013: 71 · 2012: 64
- FWCI
- 38.97
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- Universidad de Chile (submittedVersion)
- Funders
- Tinker Foundation
- Wellcome Trust
- Royal Society
- Deutsche Forschungsgemeinschaft
- Bundesministerium für Bildung und Forschung
- Rheinische Friedrich-Wilhelms-Universität Bonn
- National Institutes of Health
- Directorate for Biological Sciences
- National Institute of Child Health and Human Development
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Neuroscience › Neurology › Neurological diseases and metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
- Keywords
- ATP13A2, P-type ATPase, Kufor-Rakeb syndrome, PARK9, autosomal recessive inheritance, loss-of-function mutations, neurodegeneration, endoplasmic reticulum retention, proteasomal degradation, protein misfolding
- MeSH terms
- Adenosine Triphosphatases, Dementia, Endoplasmic Reticulum, Female, Proton-Translocating ATPases, Humans, Lysosomes, Male, Mesencephalon, Mutation, Neurons, Parkinsonian Disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.